A Tasmanian man in his 40s has died from a rare blood clotting disorder after receiving his first dose of the AstraZeneca coronavirus vaccine.
State public health officials said on Thursday that the man, who died last weekend, was a confirmed case of thrombocytopenia syndrome (TTS).
"On behalf of the Tasmanian government, and personally, I extend my deepest sympathies to the man's family, friends and loved one," Health Minister Jeremy Rockliff said.
The man was vaccinated in a Tasmanian state vaccination clinic.
Tasmanian State Health Commander Kath Morgan-Wicks said TTS was a rare but serious condition that affects two in 100,000 people who receive their first dose of the AstraZecena vaccine in Australia.
She said the determination of the man's death would be confirmed by the coroner.
The Therapeutic Goods Administration was also notified of a 48-year-old Victorian woman's death linked to AstraZeneca and TTS.
